However, overexpression of VASN in prostate tumor tissue and in serum from PCa patients and the subsequent promotion of cell proliferation and PCa progression have already been reported, in agreement with other types of cancer [90]. The gene discussed is VASN; the disease is posterior cortical atrophy.